IP Library › Granted Patent US 12,201,436
Granted Patent B2
US 12,201,436 · App. 18/297,341 · Granted Jan 21, 2025

Wireless nerve integrity monitoring systems and devices

Inventors: Richard L. Brown (Mesa, AZ); John G. Pollock (Peoria, AZ); Kevin L. McFarlin (St. Johns, FL); Randal C. Schulhauser (Phoenix, AZ)
Assignee: Medtronic Xomed, Inc.
A61B5/4041A61B1/00004A61B1/00016A61B1/00036A61B1/2673A61B5/0002A61B5/0004A61B5/0008A61B5/0024A61B5/0084A61B5/01A61B5/02055A61B5/11A61B5/14539A61B5/1473A61B5/296A61B5/316A61B5/389A61B5/4848A61B5/6833A61B5/6843A61B5/6848A61B5/6852A61B5/7475A61M16/04A61M16/0443A61N1/36031A61N1/36034A61B5/024A61B5/0816A61B5/1107A61B2560/0209A61B2562/0209A61M2205/3569A61M2205/3592A61M2205/36A61M2205/502A61M2205/52A61M2205/8206A61M2230/06A61M2230/42A61M2230/50A61M2230/60A61M2230/63
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,201,436
App. No.
18/297,341
Granted
Jan 21, 2025
Kind
B2
Abstract

A nerve integrity monitoring device includes a control module and a physical layer module. The control module is configured to generate a payload request. The payload request (i) requests a data payload from a sensor in a wireless nerve integrity monitoring network, and (ii) indicates whether a stimulation probe device is to generate a stimulation pulse. The physical layer module is configured to (i) wirelessly transmit the payload request to the sensor and the stimulation probe device, or (ii) transmit the payload request to a console interface module. The physical layer module is also configured to, in response to the payload request, (i) receive the data payload from the sensor, and (ii) receive stimulation pulse information from the stimulation probe device. The data payload includes data corresponding to an evoked response of a patient. The evoked response is generated based on the stimulation pulse.

Claims (15)

1. A nerve integrity monitoring system, comprising:

a processor configured to generate a payload request, wherein the payload request (i) requests a data payload from at least one first type sensor and at least one second type sensor in a wireless nerve integrity monitoring network, and (ii) indicates whether a stimulation probe device is to generate a stimulation pulse;

a transceiver operably associated with the processor, the transceiver configured to;

wirelessly transmit the payload request to the at least one of the first type sensor or the at least one of the second type sensor and the stimulation probe device, and

in response to the payload request, (i) receive the data payload from the at least one of the first type sensor or the at least one of the second type sensor, and (ii) receive stimulation pulse information from the stimulation probe device, wherein the data payload includes data corresponding to an evoked response of a patient, and wherein the evoked response is generated based on the stimulation pulse; and

an electrode operably associated with the processor and configured to supply an inverted common node noise signal to a patient to attenuate a corresponding common node signal detected on the at least one of the first type sensor or the at least one of the second type sensor.

2. The nerve integrity monitoring system of claim 1 , wherein the transceiver is configured to (i) receive a radio frequency signal from the at least one first type sensor or the at least one second type sensor, and (ii) down convert the radio frequency signal to a base band signal.

3. The nerve integrity monitoring system of claim 2 , wherein the processor is configured to display versions of the base band signal.

4. The nerve integrity monitoring system of claim 1 , wherein the payload request comprises slot status words, wherein each of the slot status words indicates whether a time slot is allocated to the at least one first type sensor or the at least one second type sensor or another sensor.

5. The nerve integrity monitoring system of claim 1 , wherein the payload request comprises request sequencer bits indicating which of a series of synchronization intervals the at least one first type sensor or the at least one second type sensor is to transmit data to the transceiver.

6. The nerve integrity monitoring system of claim 1 , wherein the payload request indicates whether each of a plurality of time slots, in each of a plurality of synchronization intervals is: available; in a process of being assigned; or designated to the at least one first type sensor or the at least one second type sensor or to another sensor.

7. The nerve integrity monitoring system of claim 1 , wherein the processor is configured to detect a common node noise signal from at least one of the first type sensors or at least one of the second type sensors, invert the common node noise signal, filter the inverted common node signal, and feedback the inverted and filtered common node signal back to the patient.

8. The nerve integrity monitoring system of claim 7 , wherein the inverted and filtered common node signal fed back to the patient is configured to cancel low frequency noise.

9. The nerve integrity monitoring system of claim 8 , wherein the inverted and filtered common node signal fed back to the patient attenuates respective voltage signals from the at least one of the first type sensor or at least one of the second type sensors and is used to monitor at least one of evoked tissue response signals, heart rate, respiration rate, or muscle spasms.

10. The nerve integrity monitoring system of claim 7 , wherein the inverted and filtered common node signal is in the range of 50 Hz to 60 Hz.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2023
From: BROWN, RICHARD L.; POLLOCK, JOHN G.; MCFARLIN, KEVIN L.; SCHULHAUSER, RANDAL C.
To: MEDTRONIC XOMED, INC.
Reel/Frame 063261/0408 →
Continuity (4)
Division 16531309 · Aug 5, 2019
Division 15883395 · Jan 30, 2018
Division 14455258 · Aug 8, 2014
Related Publication 20230240587A1 · Aug 3, 2023
References Cited (301)
US 4265237A · Schwanbom et al. · 1981 [cited by applicant]
US 4630263A · Townsend et al. · 1986 [cited by applicant]
US 4639263A · Kulikauskas · 1987 [cited by examiner]
US 5019724A · McClure · 1991 [cited by examiner]
US 5116332A · Lottick · 1992 [cited by applicant]
US 5555277A · Lawrence · 1996 [cited by examiner]
US 5767791A · Stoop et al. · 1998 [cited by applicant]
US 5921939A · Danielsson et al. · 1999 [cited by applicant]
US 6026321A · Miyata et al. · 2000 [cited by applicant]
US 6212427B1 · Hoover · 2001 [cited by applicant]
US 6752816B2 · Culp et al. · 2004 [cited by applicant]
US 7216001B2 · Hacker et al. · 2007 [cited by applicant]
US 7236822B2 · Dobak, III · 2007 [cited by applicant]
US 7292886B1 · Kroll · 2007 [cited by applicant]
US 7496407B2 · Odderson · 2009 [cited by applicant]
US 7689292B2 · Hadzic et al. · 2010 [cited by applicant]
US 7789833B2 · Urbano et al. · 2010 [cited by applicant]
US 7987001B2 · Teichman et al. · 2011 [cited by applicant]
US 7993269B2 · Donofrio et al. · 2011 [cited by applicant]
US 8068910B2 · Gerber et al. · 2011 [cited by applicant]
US 8126736B2 · Anderson et al. · 2012 [cited by applicant]
US 8255045B2 · Gharib et al. · 2012 [cited by applicant]
US 8374673B2 · Adcox et al. · 2013 [cited by applicant]
US 8498717B2 · Lee et al. · 2013 [cited by applicant]
US 8515520B2 · Brunnett et al. · 2013 [cited by applicant]
US 8568312B2 · Cusimano Reaston et al. · 2013 [cited by applicant]
US 8568317B1 · Gharib et al. · 2013 [cited by applicant]
US 8594779B2 · Denison et al. · 2013 [cited by applicant]
US 8670830B2 · Carlson et al. · 2014 [cited by applicant]
US 8680986B2 · Costantino · 2014 [cited by applicant]
US 8688237B2 · Stanislaus et al. · 2014 [cited by applicant]
US 8805527B2 · Mumford et al. · 2014 [cited by applicant]
US 8886280B2 · Kartush · 2014 [cited by applicant]
US 8892259B2 · Bartol et al. · 2014 [cited by applicant]
US 8926509B2 · Magar et al. · 2015 [cited by applicant]
US 8956418B2 · Wasielewski et al. · 2015 [cited by applicant]
US 8989855B2 · Murphy et al. · 2015 [cited by applicant]
US 9031658B2 · Chiao et al. · 2015 [cited by applicant]
US 9078671B2 · Beale et al. · 2015 [cited by applicant]
US 9084550B1 · Bartol et al. · 2015 [cited by applicant]
US 9084551B2 · Brunnett et al. · 2015 [cited by applicant]
US 9204830B2 · Zand et al. · 2015 [cited by applicant]
US 9918669B2 · Brown et al. · 2018 [cited by applicant]
US 10039915B2 · McFarlin et al. · 2018 [cited by applicant]
US 10123731B2 · Brown et al. · 2018 [cited by applicant]
US 10368793B2 · Brown et al. · 2019 [cited by applicant]
US 10398369B2 · Brown et al. · 2019 [cited by applicant]
US 10849517B2 · Cantwell et al. · 2020 [cited by applicant]
US 10987506B2 · McFarlin et al. · 2021 [cited by applicant]
US 20020109621A1 · Khair et al. · 2002 [cited by applicant]
US 20020111624A1 · Witt et al. · 2002 [cited by applicant]
US 20030171747A1 · Kanehira et al. · 2003 [cited by applicant]
US 20030181798A1 · Ai-Ali · 2003 [cited by applicant]
US 20040135528A1 · Yasohara et al. · 2004 [cited by applicant]
US 20050075067A1 · Lawson et al. · 2005 [cited by applicant]
US 20050075578A1 · Gharib et al. · 2005 [cited by applicant]
US 20050085743A1 · Hacker et al. · 2005 [cited by applicant]
US 20050131464A1 · Heinrich et al. · 2005 [cited by applicant]
US 20050149143A1 · Libbus et al. · 2005 [cited by applicant]
US 20050159659A1 · Sawan et al. · 2005 [cited by applicant]
US 20050215993A1 · Phan · 2005 [cited by applicant]
US 20050267529A1 · Crockett et al. · 2005 [cited by applicant]
US 20060025702A1 · Sterrantino et al. · 2006 [cited by applicant]
US 20060047215A1 · Newman · 2006 [cited by examiner]
US 20060200219A1 · Thrope et al. · 2006 [cited by applicant]
US 20060241725A1 · Libbus et al. · 2006 [cited by applicant]
US 20060276702A1 · McGinnis · 2006 [cited by applicant]
US 20070083193A1 · Werneth et al. · 2007 [cited by applicant]
US 20070191915A1 · Strother et al. · 2007 [cited by applicant]
US 20070260293A1 · Carpenter et al. · 2007 [cited by applicant]
US 20070270678A1 · Fadem et al. · 2007 [cited by applicant]
US 20070270918A1 · De Bel et al. · 2007 [cited by applicant]
US 20070282217A1 · McGinnis et al. · 2007 [cited by applicant]
US 20080051673A1 · Kong et al. · 2008 [cited by applicant]
US 20080077198A1 · Webb et al. · 2008 [cited by applicant]
US 20080183190A1 · Adcox et al. · 2008 [cited by applicant]
US 20080183915A1 · Iima · 2008 [cited by applicant]
US 20080214903A1 · Orbach · 2008 [cited by applicant]
US 20080218393A1 · Kuramochi et al. · 2008 [cited by applicant]
US 20080300650A1 · Gerber et al. · 2008 [cited by applicant]
US 20080306348A1 · Kuo et al. · 2008 [cited by applicant]
US 20090024187A1 · Erickson et al. · 2009 [cited by applicant]
US 20090054804A1 · Gharib et al. · 2009 [cited by applicant]
US 20090157141A1 · Chiao et al. · 2009 [cited by applicant]
US 20090177112A1 · Gharib et al. · 2009 [cited by applicant]
US 20090182322A1 · D'Amelio et al. · 2009 [cited by applicant]
US 20090182328A1 · D'Amelio et al. · 2009 [cited by applicant]
US 20090182330A1 · D'Amelio et al. · 2009 [cited by applicant]
US 20090182331A1 · D'Amelio et al. · 2009 [cited by applicant]
US 20090186577A1 · Ross et al. · 2009 [cited by applicant]
US 20090240117A1 · Chmiel et al. · 2009 [cited by applicant]
US 20090299439A1 · Mire et al. · 2009 [cited by applicant]
US 20100036280A1 · Ballegaard et al. · 2010 [cited by applicant]
US 20100130913A1 · Baynham et al. · 2010 [cited by applicant]
US 20100145178A1 · Kartush · 2010 [cited by applicant]
US 20100152811A1 · Flaherty · 2010 [cited by applicant]
US 20100152812A1 · Flaherty et al. · 2010 [cited by applicant]
US 20100160731A1 · Giovannini et al. · 2010 [cited by applicant]
US 20100168561A1 · Anderson · 2010 [cited by applicant]
US 20100191311A1 · Scheiner et al. · 2010 [cited by applicant]
US 20100280568A1 · Bulkes et al. · 2010 [cited by applicant]
US 20110004207A1 · Wallace et al. · 2011 [cited by applicant]
US 20110028860A1 · Chenaux et al. · 2011 [cited by applicant]
US 20110071418A1 · Stellar et al. · 2011 [cited by applicant]
US 20110160731A1 · Bleich et al. · 2011 [cited by applicant]
US 20110190596A1 · Hacker et al. · 2011 [cited by applicant]
US 20110230734A1 · Fain et al. · 2011 [cited by applicant]
US 20110230782A1 · Bartol et al. · 2011 [cited by applicant]
US 20110230783A1 · Bartol et al. · 2011 [cited by applicant]
US 20110237924A1 · McGusty et al. · 2011 [cited by applicant]
US 20110245647A1 · Stanislaus et al. · 2011 [cited by applicant]
US 20110270120A1 · McFarlin et al. · 2011 [cited by applicant]
US 20110270121A1 · Johnson et al. · 2011 [cited by applicant]
US 20120004516A1 · Eng et al. · 2012 [cited by applicant]
US 20120071784A1 · Melkent et al. · 2012 [cited by applicant]
US 20120245439A1 · Andre et al. · 2012 [cited by applicant]
US 20120330384A1 · Perryman et al. · 2012 [cited by applicant]
US 20130030257A1 · Nakata et al. · 2013 [cited by applicant]
US 20130090641A1 · McKinney et al. · 2013 [cited by applicant]
US 20130116678A1 · Koss et al. · 2013 [cited by applicant]
US 20130245722A1 · Ternes et al. · 2013 [cited by applicant]
US 20130253334A1 · Al-Ali et al. · 2013 [cited by applicant]
US 20130261422A1 · Gilmore et al. · 2013 [cited by applicant]
US 20130304059A1 · Allen, IV et al. · 2013 [cited by applicant]
US 20130345701A1 · Allen, IV et al. · 2013 [cited by applicant]
US 20140005753A1 · Carbunaru · 2014 [cited by applicant]
US 20140039491A1 · Bakos et al. · 2014 [cited by applicant]
US 20140058284A1 · Bartol et al. · 2014 [cited by applicant]
US 20140067007A1 · Drees et al. · 2014 [cited by applicant]
US 20140073985A1 · Sakai et al. · 2014 [cited by applicant]
US 20140074084A1 · Engeberg et al. · 2014 [cited by applicant]
US 20140180169A1 · Peters et al. · 2014 [cited by applicant]
US 20140275849A1 · Acquista · 2014 [cited by applicant]
US 20140275914A1 · Li et al. · 2014 [cited by applicant]
US 20140277259A1 · Rosenberg et al. · 2014 [cited by applicant]
US 20140303452A1 · Ghaffari · 2014 [cited by applicant]
US 20140316229A1 · Tognetti et al. · 2014 [cited by applicant]
US 20140336635A1 · Hart et al. · 2014 [cited by applicant]
US 20140364920A1 · Doan et al. · 2014 [cited by applicant]
US 20150012066A1 · Underwood · 2015 [cited by applicant]
US 20150088029A1 · Wybo · 2015 [cited by applicant]
US 20150112325A1 · Whitman · 2015 [cited by applicant]
US 20150157237A1 · Murphy et al. · 2015 [cited by applicant]
US 20150173636A1 · Mokelke et al. · 2015 [cited by applicant]
US 20150202395A1 · Fromentin · 2015 [cited by applicant]
US 20150230749A1 · Gharib et al. · 2015 [cited by applicant]
US 20150238260A1 · Nau, Jr. · 2015 [cited by applicant]
US 20150250423A1 · Hacker et al. · 2015 [cited by applicant]
US 20160015299A1 · Chan et al. · 2016 [cited by applicant]
US 20160038072A1 · Brown et al. · 2016 [cited by applicant]
US 20160038073A1 · Brown et al. · 2016 [cited by applicant]
US 20160038074A1 · Brown et al. · 2016 [cited by applicant]
US 20160038225A1 · Couture et al. · 2016 [cited by applicant]
US 20160199659A1 · Jiang et al. · 2016 [cited by applicant]
US 20160206362A1 · Mehta et al. · 2016 [cited by applicant]
US 20160235999A1 · Nuta et al. · 2016 [cited by applicant]
US 20160262699A1 · Goldstone et al. · 2016 [cited by applicant]
US 20160270679A1 · Mahon et al. · 2016 [cited by applicant]
US 20160287112A1 · McFarlin et al. · 2016 [cited by applicant]
US 20160287861A1 · McFarlin et al. · 2016 [cited by applicant]
US 20160317053A1 · Srivastava · 2016 [cited by applicant]
US 20170202570A1 · Shelton, IV et al. · 2017 [cited by applicant]
US 20170202598A1 · Shelton, IV et al. · 2017 [cited by applicant]
US 20180078161A1 · Cantwell et al. · 2018 [cited by applicant]
US 20190021643A1 · Brown et al. · 2019 [cited by applicant]
US 20190021644A1 · Brown et al. · 2019 [cited by applicant]
AU 2016244152A1 · 2017 [cited by applicant]
CA 2957385A1 · 2016 [cited by applicant]
CN 2610843Y · 2004 [cited by applicant]
CN 101528303A · 2009 [cited by applicant]
CN 101594830A · 2009 [cited by applicant]
CN 101594906A · 2009 [cited by applicant]
CN 102046098A · 2011 [cited by applicant]
CN 102238904A · 2011 [cited by applicant]
CN 102762251A · 2012 [cited by applicant]
CN 103608069A · 2014 [cited by applicant]
CN 104203129A · 2014 [cited by applicant]
CN 105744887A · 2016 [cited by applicant]
EP 1587418A1 · 2005 [cited by applicant]
GB 2452158A · 2009 [cited by applicant]
JP 2004500217A · 2004 [cited by applicant]
JP 2004503266A · 2004 [cited by applicant]
JP 2008508049A · 2008 [cited by applicant]
JP 2008519609A · 2008 [cited by applicant]
JP 2008538996A · 2008 [cited by applicant]
JP 2009268016A · 2009 [cited by applicant]
JP 2010515487A · 2010 [cited by applicant]
JP 2011224085A · 2011 [cited by applicant]
JP 2012516205A · 2012 [cited by applicant]
JP 2013503015A · 2013 [cited by applicant]
JP 2013506507A · 2013 [cited by applicant]
JP 2013505080A · 2013 [cited by applicant]
JP 2013525002A · 2013 [cited by applicant]
JP 2014117328A · 2014 [cited by applicant]
JP 2014524279A · 2014 [cited by applicant]
JP 2015513988A · 2015 [cited by applicant]
JP 2018514258A · 2018 [cited by applicant]
KR 20130052534A · 2013 [cited by applicant]
TW 331027B · 2010 [cited by applicant]
WO 9525472A1 · 1995 [cited by applicant]
WO 9937359A1 · 1999 [cited by applicant]
WO 0178831A2 · 2001 [cited by applicant]
WO 02082982A1 · 2002 [cited by applicant]
WO 03026482A2 · 2003 [cited by applicant]
WO 2004064632A1 · 2004 [cited by applicant]
WO 2006026482A2 · 2006 [cited by applicant]
WO 2008012398A1 · 2008 [cited by applicant]
WO 2010090835A1 · 2010 [cited by applicant]
WO 2011035311A1 · 2011 [cited by applicant]
WO 2011041684A2 · 2011 [cited by applicant]
WO 2011136962A1 · 2011 [cited by applicant]
WO 2011150502A2 · 2011 [cited by applicant]
WO 2012129574A2 · 2012 [cited by applicant]
WO 2013019757A2 · 2013 [cited by applicant]
WO 2013151770A1 · 2013 [cited by applicant]
WO 2013160549A1 · 2013 [cited by applicant]
WO 2015069962A1 · 2015 [cited by applicant]
WO 2015123100A1 · 2015 [cited by applicant]
WO 2016160477A1 · 2016 [cited by applicant]
Chinese Office Action regarding Application No. 201780071018.2, mailed Aug. 24, 2021. [cited by applicant]
Office Action regarding Japanese Patent Application No. 2017-552026, dated Oct. 13, 2021 (with English Translation). [cited by applicant]
Japanese Office Action regarding Japanese Patent Application No. 2020-135550, dated Dec. 28, 2021. [cited by applicant]
Korean Office Action regarding Application No. 1020197010841, dated Feb. 3, 2022. [cited by applicant]
Japanese Office Action regarding Japanese Patent Application No. 2019515506, dated Feb. 4, 2022. [cited by applicant]
Canadian Office Action regarding Canadian Application No. 3099052, dated Feb. 18, 2022. [cited by applicant]
European Office Action regarding Patent Application No. 20176316.6, dated Dec. 7, 2021. [cited by applicant]
Canadian Examination Report regarding Application No. 2,981,636, mailed Mar. 9, 2022. [cited by applicant]
Chinese Office Action regarding Patent Application No. 201780071018.2, dated Mar. 24, 2022. [cited by applicant]
Japanese Office Action regarding Patent Application No. 2019-515506, dated Apr. 22, 2022. [cited by applicant]
Summons to Attend Oral Proceedings regarding European Patent Application No. 201763166, dated Sep. 26, 2022. [cited by applicant]
Japanese Office Action regarding Application No. 2020-134805, dated May 11, 2022. [cited by applicant]
First Office Action—Request for the submission of an Opinion, corresponding to Korean Patent Application No. 10-2017-7032060 (corresponding to PCT/US2016/023910), dated Oct. 26, 2022. [cited by applicant]
European Patent Office—Office Action corresponding to EP 17 778 021.0, dated Nov. 22, 2022. [cited by applicant]
China-Decision on Rejection, corresponding to Chinese Application No. 201780071018.2, Date of Dispatch: Sep. 23, 2022. [cited by applicant]
European Patent Office Brief Communication regarding Oral Proceedings, Date: Jan. 12, 2023, corresponding to European Application No. 20176316.3. [cited by applicant]
Cypress Perform. SPI-based CyFi™ Transceiver Data Sheet. Cypress Semiconductor Corporation. (Jun. 25, 2009) pp. 1-45. [cited by applicant]
Hurley “Physiotherapy for Sleep Disturbance in Chronic Low Pack Pain: a Feasibility Randomised Controlled Trial” BMC Musculoskeletal Disorders; 11 pages; 2010. [cited by applicant]
International Search Report and Written Opinion for PCT/US2015/043844 mailied Jan. 12, 2016. [cited by applicant]
International Search Report and Written Opinion for PCT/US2016/023903 dated Sep. 19, 2016 which claims benefit of U.S. Appl. No. 14/678,485, filed Apr. 3, 2015. [cited by applicant]
International Search Report and Written Opinion for PCT/US2016/023910 dated Aug. 5, 2016 which claims benefit of U.S. Appl. No. 14/578,452, filed Apr. 3, 2015. [cited by applicant]
Invitation to Pay Additional Fees mailed Jun. 10, 2016 for International Application No. PCT/US2016/023903 which corresponds to U.S. Appl. No. 14/678,485, filed Apr. 3, 2015. [cited by applicant]
Wustrack “Change in Physical Activity One Year after Lumbar Decompression with or without Fusion, is it Correlated to Self-Reported Outcome Scores?” Proceedings of NASS 20th Annual Meeting/The Spine Journal 5 (2005) IS-… [cited by applicant]
Wustrack “Physical Activity does not correlate with HRQL Scores in Patients with Degeneratie Lumbar Conditions” Proceedings of the NASS 20th Annual Meeting/The Spine Journal 5 (2005) IS-189S. [cited by applicant]
International Preliminary Report on Patentability mailed Oct. 12, 2017 in corresponding International Application No. PCT/US2016/023903. [cited by applicant]
International Preliminary Report on Patentability mailed Oct. 12, 2017 in corresponding/related International Application No. PCT/US2016/023910. [cited by applicant]
Australian Examination Report mailed Dec. 8, 2018 in corresponding/related Australian Application No. 2016244152. [cited by applicant]
International Search Report and Written Opinion mailed Nov. 29, 2017 in corresponding International Application No. PCT/US2017/051825. [cited by applicant]
Canadian Office Action mailed Dec. 11, 2017 in corresponding/related Canadian Application No. 2,957,385. [cited by applicant]
Australian Office Action mailed Feb. 8, 2018 in corresponding/related Australian Application No. 2015301110. [cited by applicant]
Japanese Office Action mailed Mar. 22, 2018 in corresponding/related Australian Application No. 2017-506854. [cited by applicant]
Canadian Office Action mailed Jul. 27, 2018 in corresponding/related Canadian Application No. 2,981,635. [cited by applicant]
Korean Office Action mailed Aug. 21, 2018 in corresponding/related Korean Application No. 10-2017-7006340. [cited by applicant]
Japanese Office Action mailed Nov. 26, 2018 in corresponding/related Japanese Application No. 2017-506854. [cited by applicant]
Office Action mailed Feb. 13, 2019 in corresponding/related European Application No. 15753542.8. [cited by applicant]
Office Action mailed Feb. 20, 2019 in corresponding/related Korean Application No. 10-2017-7032059. [cited by applicant]
International Preliminary Report on Patentability mailed Mar. 28, 2019 in corresponding/related International Application No. PCT/US2017/051825. [cited by applicant]
Office Action mailed Apr. 22, 2019 in corresponding/related Chinese Application No. 201580053580.3. [cited by applicant]
Office Action mailed Jun. 20, 2019 in corresponding/related Canadian Application No. 2,981,635. [cited by applicant]
Medtronic Xomed Inc. “APS Electrode Stimulator” Brochure, 10 pages, 2010. [cited by applicant]
Office Action regarding European Patent Application No. 16712713.3, dated Dec. 6, 2019. [cited by applicant]
Office Action regarding Canadian Patent Application No. 2957385, dated Dec. 12, 2019. [cited by applicant]
Office Action regarding Australian Patent Application No. 2016243081, dated Dec. 21, 2019. [cited by applicant]
Office Action regarding Chinese Patent Application No. 201580053580.3, dated Jan. 7, 2020 (with English Translation). [cited by applicant]
Office Action mailed Feb. 26, 2020 in corresponding/related Japanese Application No. 2019-050923. [cited by applicant]
Examination Report mailed Feb. 28, 2020 in corresponding/related Australian Application No. 2019201702. [cited by applicant]
Office Action mailed Feb. 5, 2020 in corresponding/related Indian Application No. 201717004436. [cited by applicant]
Office Action regarding corresponding/related Japanese Patent Application No. 2017552026, dated Mar. 27, 2020. [cited by applicant]
Office Action mailed Apr. 2, 2020 in corresponding/related Chinese Application No. 201680030281.2. [cited by applicant]
Office Action mailed Apr. 14, 2020 in corresponding/related Chinese Application No. 201680030207.0. [cited by applicant]
Office Action mailed Jun. 30, 2020 in corresponding/related Chinese Application No. 201580053580.3. [cited by applicant]
Extended European Search Report mailed Jul. 1, 2020 in corresponding/related European Application No. 20176316.6. [cited by applicant]
Office Action mailed Aug. 18, 2020 in corresponding/related Brazilian Application No. BR112017002470-5. [cited by applicant]
Office Action mailed Aug. 26, 2020 in corresponding/related Korean Application No. 10-2019-7012435. [cited by applicant]
Office Action mailed Aug. 26, 2020 in corresponding/related Korean Application No. 10-2020-7007858. [cited by applicant]
Office Action mailed Sep. 16, 2020 in corresponding/related Chinese Application No. 201680030207.0. [cited by applicant]
Examination Report mailed Sep. 8, 2020, in corresponding/related Australian Application No. 2019203347. [cited by applicant]
Examination Report mailed Sep. 8, 2020, in corresponding/related Australian Application No. 2019203348. [cited by applicant]
Office Action mailed Nov. 3, 2020, in corresponding/related Canadian Application No. 2,957,385. [cited by applicant]
Office Action mailed Nov. 10, 2020 in corresponding/related Japanese Application No. Japanese Patent Appln. No. 2017-552026. [cited by applicant]
Pre-Appeal Examination Report regarding Japanese Patent Application No. 2017-552026, dated Feb. 16, 2021. [cited by applicant]
Office Action regarding Chinese Patent Application No. 201580053580.3, dated Mar. 1, 2021. [cited by applicant]
Office Action regarding European Patent Application No. 16715204.0, dated May 21, 2021. [cited by applicant]
Rich Vogel, Understanding Anodal and Cathodal Stimulation, The ASNM Monitor, 2017, https://www.asnm.org/blogpost/1635804/290597/Understanding-Anodal-and-Cathodal-Stimulation. [cited by applicant]
Office Action regarding Japanese Patent Application No. 2020-134805, dated Jul. 13, 2021 with English translation. [cited by applicant]
Office Action regarding Japanese Patent Application No. 2020-135550, dated Jul. 5, 2021 with English translation. [cited by applicant]
U.S. Appl. No. 14/678,452, filed Apr. 3, 2015, Kevin L. McFarlin. [cited by applicant]
U.S. Appl. No. 16/142,224, filed Sep. 26, 2018, Richard L. Brown. [cited by applicant]
U.S. Appl. No. 16/142,238, filed Sep. 26, 2018, Richard L. Brown. [cited by applicant]
U.S. Appl. No. 16/531,309, filed Aug. 5, 2019, Richard L. Brown. [cited by applicant]
U.S. Appl. No. 17/029,472, filed Sep. 23, 2020, Matthew L. Cantwell. [cited by applicant]
U.S. Appl. No. 17/240,375, filed Apr. 26, 2021, Kevin L. McFarlin. [cited by applicant]
U.S. Appl. No. 18/168,081, filed Feb. 13, 2023, Richard L. Brown. [cited by applicant]
U.S. Appl. No. 14/455,258, filed Aug, 8, 2014, Richard L. Brown. [cited by applicant]
U.S. Appl. No. 14/455,285, filed Aug. 8, 2014, Richard L. Brown. [cited by applicant]
U.S. Appl. No. 14/455,313, filed Aug. 8, 2014, Richard L. Brown. [cited by applicant]
U.S. Appl. No. 14/678,485, filed Apr. 3, 2015, Kevin L. McFarlin. [cited by applicant]
U.S. Appl. No. 15/269,051, filed Sep. 19, 2016, Matthew L. Cantwell. [cited by applicant]
U.S. Appl. No. 15/883,395, filed Jan. 30, 2018, Richard L. Brown. [cited by applicant]
U.S. Appl. No. 16/027,510, filed Jul. 5, 2018, Kevin L. McFarlin. [cited by applicant]
U.S. Appl. No. 16/552,708, filed Aug. 27, 2019, Richard L. Brown. [cited by applicant]
European Search Report 23195973.5 dated Feb. 21, 2024, 4pp. [cited by applicant]